The enantiomeric analysis of urine collected from rats The AM/MA ratio from I-deprenyl users (0.33 • 0.03) was significantly higher than the ratio from MA abusers (0.20 • 0.12).
Introduction l-Deprenyl (R(-)-N-methyl-N-(1-phenyl-2-propyl)-2-propar-
gylamine, selegiline) is a selective and irreversible inhibitor of monoamine oxidase type B that has been widely used in the treatment of Parkinson's disease (PD) (1) (2) (3) . It has been reported that l-deprenyl is extensively metabolized by the liver, forming l-enantiomers of desmethylselegiline (DMS), methamphetamine (MA), amphetamine (AM), and their conjugated p-hydroxy derivatives ( Figure 1 ) (4, 5) . The predominant drug of abuse in Korea is d-MA (brand name "Philopon"), so the urine from MA abusers usually contains unchanged d-enantiomer of MA and its metabolite, d-AM (6, 7) . l-Deprenyl has been marketed recently in Korea as a therapeutic drug for the treatment of PD, but the metabolites of l-deprenyl, I-MA, and l-AM, as well as d-and dl-MA (AM), are all controlled by the Korean government as illicit psychotropic drugs. It is, therefore, necessary to distinguish legitimate therapeutic drug use from illegal drug abuse.
l-Deprenyl use has been reported to be distinguished from d-MA abuse by chiral analysis of MA and AM in biological specimens. Numerous analytical studies have addressed the enantiomeric separation of MA and AM using gas chromatography (GC) or high-performance liquid chromatography (HPLC) following derivatization with a chiral agent (8) (9) (10) (11) (12) and using chiral columns (13) (14) (15) . In previous studies (16, 17) , we have detected I-MA and/-AM in rat urine following oral administration of l-deprenyl and d-MA and d-AM in urine from MA abusers by gas chromatographic-mass spectrometric ( 
GC-MS) analysis following derivatization with (S)-(-)-N-
(trifluoroacetyl)-prolyl chloride. During these analyses, the data interpretation tended to be hampered by the optical impurity of (S)-(-)-N-(trifluoroacetyl)-prolyl chloride and the complexity of extraction steps. Besides the mentioned analytical techniques, there has been growing interest in the application of capillary electrophoresis (CE) for enantiomer separations, and numerous possibilities are available for drugs such as AM analogues. Advantages offered by CE include direct chiral resolution, small injection volumes, high separation efficiency, high speed, and low cost. The chiral selectors applied in CE analysis are usually used as buffer additives, the most often used being derivatives (18) (19) (20) . Different [3-CD derivatives such as heptakis-(2,6-di-O-methyl)-[3-CD or epichlorhydrin ~-CD have been used in chiral separations of deprenyl, MA, AM, DMS, and ephedrine by CE (21, 22) . Nevertheless, few publications have dealt with the CE analysis of chiral metabolites of l-deprenyl and MA from biological specimens after the administration of drugs.
In the present study, which uses the cyclodextrin-modified CE analytic method developed by Heo et al. (23) , the metabolic pattern of l-deprenyl was compared with the metabolism of d-or dI-MA in urine collected from rats administered with l-deprenyl, d-MA, or dl-MA, and from five healthy volunteers who ingested l-deprenyl. Urine samples were also collected from eight illegal drug abusers for the comparison of therapeutic drug (l-deprenyl) use with abused drug (d-MA) use. We have employed CE with the use of an acidic carboxy methylated-[3-cyclodextrin (CMCD) as a chiral selector for the analysis of the urine samples, and this improved the resolution of chiral separation of optical isomers and simplified the analysis steps. 
Experimental

Chemicals and reagents
Apparatus
A P/ACE 5500 (Beckman, CA) CE system equipped with a diode-array detector set at 203 nm was used for the separation and quantitation of the metabolites of l-deprenyl and MA. A fused-silica capillary (57-cm x 50-1Jm i.d.) with an effective length of 50 cm to the detector window was used. For quantitative work, the instrument was operated at 25 kV and at a temperature of 15~ Samples were injected by pressure at 50 mbar for 20 s. P/ACE Station software version 1.0 was used for data collection.
Animals, human subjects, drug administration, and urine sampling were 50 ng/mL through the whole procedure at a signal-tonoise ratio of 3. The urine samples were extracted as described.
Extraction of urine samples
Rat urine (0.5-1 mL) or human urine (2-4 mL) samples were mixed with dl-methoxyamphetamine (5 pg/mL urine), 1N NaOH (200 IJL/mL urine), and saturated NaC1 (200 pL/mL urine) and extracted with ethylacetate (500 pL/mL urine) by shaking for 30 rain and centrifugation at 3000 rpm for 10 min. The organic layer was transferred to a Eppendorf tube ( 1.5 mL) and extracted with 50 pL of 0.1N HC]. After removing the organic phase, the residual aqueous phase was analyzed by CE.
Statistical analysis
Student's t-test was used to determine statistical significance; p values of < 0.05 were regarded as being significantly different.
Results and Discussion
Simultaneous identification of/-deprenyl, MA, and their metabolites in rat and human urine Calibration curves for each standard in rat urine were linear over the concentration ranges studied (0. respectively. Optical isomers of AM, MA, and DMS were simultaneously detected by CE analysis using CMCD as a chiral selector. Figure 2A is standard drugs were in the range of 92.0-105.8%. The precision (reproducibility) of migration times for each standard substance run three times was satisfactory at a concentration of 1 pg/mL with coefficients of variation (CV) of the migration times at 0.31-1.00%. In a previous study (23) , the reproducibility of the method was more extensively assessed by repeated analyses of standard sample containing various concentrations of AM and MA spiked with a known concentration of internal standard. The CVs of the retention time were less than 0.5% for within-run precision and less than 1.0% for the between-run precision. Those of the peak areas, which were obtained from the ratios of analytes to internal standard, were less than 5% for both within-and between-run. In CE, [3-CDs are the most commonly used for enantiomeric separation as chiral selectors. The principles of chiral separation by [3- separated by CE from its enantiomer, l-AM, I-DMS, and MA enantiomers using heptakis-(2,6-di-O-methyl)- [3-cyclodextrin (21) , or separated from ephedrine and MA enantiomers using neutral epichlorhydrin , aided with the addition of an organic solvent (methanol) to be able to be resolved in one run. In the present study, CMCD, an acidic (negatively charged) chiral selector, was used because it provides better resolution for separations of isomers of MA and AM at much lower concentration than HPCD and native 13-CD, which are both neutral (23) . We established simultaneous chiral separation of deprenyl and its metabolites including DMS, MA, and AM enantiomers, excreted in rat and human urine, using the CE analytical method with better resolution and simplicity.
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Comparison of the metabolites of I-deprenyl and MA in rat and human urine
The urine collected up to 24 h after oral administration of l-deprenyl (10 mg/kg) to eight rats had a weak alkaline pH range of 7.9-8.8 and volume of 6-20 mL. In that rat urine, as shown in Figure 2B , l-AM, I-MA, l-deprenyl, and I-DMS were detected and resolved with migration times of 11.51, 12.53, 14.95, and 15.60 min, respectively. Two more peaks with migration times of 15.73 and 17.08 rain, that are assumed to be l-p-hydroxy AM and l-p-hydroxy MA, respectively, were also present in the electropherogram. Among the metabolites detected in rat urine after l-deprenyl administration, l-AM was the most abundant (/-AM > I-MA A I-DMS A l-deprenyl), and the ratios of l-AM to I-MA ranged from 1.88 to 3.52 (Table I ). In rat (Table II) . Whereas, in 24-h rat urine after administration with dl-MA (10 mg/kg), the amount of metabolites detected was in the order of d-MA > I-MA = d-AM > l-AM (Figure 2D) , and the ratios of d-AM to d-MA and l-AM to I-MA ranged from 0.41 to 1.12 and from 0.32 to 1.07, respectively (Table II) . These results indicate that the urinary metabolic ratio of AM to MA could be used to distinguish l-deprenyl treatment from d-or dl-MA treatment in rats. Kikura et al. (24) reported that HPLC analyses for metabolites of l-deprenyl and I-MA in mouse urine produced the result that the urinary AM/MA ratio following administration of l-deprenyl ranged from 0.13 to 0.3, and the ratio following I-MA administration was less than 0.1. Our resuits correspond well with this report in that the AM/MA ratio from l-deprenyl treatment is significantly higher than the ratio from MA treatment.
In human urine collected from healthy Korean male volunteers up to 24 h after oral ingestion ofl-deprenyl.HCl (10 rag), as shown in Figure 2E , peaks were detected for I-MA, l-AM, and I-DMS with migration times almost identical to those detected in rat urine spiked with standard substances (Figure 2A ) or in rat urine collected after l-deprenyl administration ( Figure 2B Mean _+ SD Table IIl . The amount of I-MA excreted was higher than l-AM in 24-h urine after l-deprenyl ingestion, which was a different pattern than rat urine, in which urinary/-AM content was higher than any of the other metabolites of l- de The present result shows that, in a similar manner to the case in rat urine, the ratio of AM to MA from l-deprenyl users was significantly higher than the corresponding ratio from d-MA abusers (Table III) . Similar results could be derived from other studies for the metabolism of l-deprenyl and I-MA in humans. Ti me (h) A study in which plasma levels of AM, MA, and N-DMS were analyzed in a healthy mate subject given a 10-rag oral dose of l-deprenyl has shown that the AM/MA ratio during the 36-h test period was 0.33 (25) . Another study has reported that the four urine specimens obtained from l-deprenyl users gave AM/MA ratios ranging from 0.37 to 0.42 (26) . Studies using the Vicks
Inhaler, which contains I-MA, have given urinary AM/MA ratios from 0 to 0.12 (7). Very recently, Hasegawa et al. (27) reported that the values of AM/MA in the urine increased from 0.24 to 0.67 along with the time after l-deprenyl administration, whereas the urinary AM/MA was less than 0.24 in 74% of the MA abusers tested. Taken together with these results, our data confirm that the metabolic pattern of AM/MA ratio between /-deprenyl use and MA abuse is distinguishable. The AM/MA ratio, therefore, could provide useful information for the differentiation of deprenyl use and MA use, especially under conditions where illicit MA and not pure d-MA was used or a tool for effective chiral separation is not available. However, it is also important to note that the metabolic ratios can give no conclusive proof of deprenyl or MA use. Although the difference in the ratio between deprenyl users and MA abusers was statistically significant in our study, two MA abusers (subjects 1 and 7) had an AM/MA ratio in the same range as that of deprenyl u s e r s .
The curves of urinary excretion rate (IJg/h) for t-deprenyl and its metabolites after oral dose of l-deprenyl to healthy volunteers are presented in Figure 3 . Both I-MA and l-AM were excreted in urine largely during the time between 3 and 12 h with the highest level at 3-6 h, and then continuously excreted 12-24 h after oral administration. On the other hand, the excretion rate ofl-DMS reached its highest level at 0-3 h and decreased rapidly. This metabolite was easily detectable only up to 9 h after a single 10-mg oral dosing. This result indicates that the detection of a specific metabolite of l-deprenyl, I-DMS, could not distinguish the therapeutic l-deprenyl use from the illegal MA abuse, as also indicated in the recent study by Hasegawa et al. (27) .
In conclusion, we performed the chiral separation of l-deprenyl and MA metabolites using a new cyclodextrin-modified CE analysis to compare the metabolic patterns of l-deprenyl and MA in rat and human urine and to distinguish illicit drug use and therapeutic drug use. Results indicate that although metabolic patterns of the drugs in rat and human bodies may be different, the AM/MA ratio from l-deprenyl use is significantly higher than the ratio from MA use in both rat and human urine. The simultaneous chiral separation for all the metabolites of/-deprenyl and MA by CE analysis used in this study could provide rapid and simple discrimination between therapeutic drug use and illegal drug abuse.
